Somatostatin: its role in health and disease
- PMID: 6134345
Somatostatin: its role in health and disease
Similar articles
-
Somatostatin--clinical implications.Ciba Found Symp. 1976;41:313-50. Ciba Found Symp. 1976. PMID: 780078 No abstract available.
-
Glucagon physiology in health and disease.Int Rev Physiol. 1977;16:151-71. Int Rev Physiol. 1977. PMID: 332652 Review. No abstract available.
-
Somatostatin, basic and clinical studies. A review.Mater Med Pol. 1980 Jan-Jun;12(1-2):28-32. Mater Med Pol. 1980. PMID: 6120265 Review. No abstract available.
-
[The endocrine pancreas. From the isolated islet to the "artificial pancreas" (author's transl)].MMW Munch Med Wochenschr. 1976 Apr 16;118(16):485-92. MMW Munch Med Wochenschr. 1976. PMID: 818514 German.
-
Somatostatin (growth hormone-release inhibiting hormone).Clin Endocrinol Metab. 1977 Mar;6(1):181-200. doi: 10.1016/s0300-595x(77)80063-7. Clin Endocrinol Metab. 1977. PMID: 196795 Review. No abstract available.
Cited by
-
Absent prolactin (PRL) response to thyrotropin releasing hormone (TRH) and somatostatin (SRIF) in at term fetus.J Endocrinol Invest. 1984 Oct;7(5):521-4. doi: 10.1007/BF03348461. J Endocrinol Invest. 1984. PMID: 6150957
-
Gastroenteropancreatic endocrine tumors.Klin Wochenschr. 1985 May 15;63(10):433-59. doi: 10.1007/BF01731493. Klin Wochenschr. 1985. PMID: 2861306 No abstract available.
-
Glucoregulation during exercise: hypoglycemia is prevented by redundant glucoregulatory systems, sympathochromaffin activation, and changes in islet hormone secretion.J Clin Invest. 1986 Jan;77(1):212-21. doi: 10.1172/JCI112279. J Clin Invest. 1986. Retraction in: J Clin Invest. 1989 Mar;83(3):1085. PMID: 3511090 Free PMC article. Retracted.